MarketBeat Instant News Alerts MarketBeat Instant News Alerts - Page 544 May 2, 2026 11:13 PM ETTenet Healthcare (NYSE:THC) Upgraded to Strong-Buy at Wall Street ZenMarketBeatNYSE:THCRead Tenet Healthcare (NYSE:THC) Upgraded to Strong-Buy at Wall Street ZenMay 2, 2026 11:13 PM ETVale (NYSE:VALE) Raised to Buy at Wall Street ZenMarketBeatNYSE:VALERead Vale (NYSE:VALE) Raised to Buy at Wall Street ZenMay 2, 2026 11:13 PM ETWisdomTree (NYSE:WT) Raised to "Buy" at Wall Street ZenMarketBeatNYSE:WTRead WisdomTree (NYSE:WT) Raised to "Buy" at Wall Street ZenMay 2, 2026 11:13 PM ETWestlake (NYSE:WLK) Lowered to "Sell" Rating by Wall Street ZenMarketBeatNYSE:WLKRead Westlake (NYSE:WLK) Lowered to "Sell" Rating by Wall Street ZenMay 2, 2026 11:13 PM ETYext (NYSE:YEXT) Cut to Hold at Wall Street ZenMarketBeatNYSE:YEXTRead Yext (NYSE:YEXT) Cut to Hold at Wall Street ZenMay 2, 2026 11:13 PM ETBARK (NYSE:BARK) Upgraded to Hold at Wall Street ZenMarketBeatNYSE:BARKRead BARK (NYSE:BARK) Upgraded to Hold at Wall Street ZenMay 2, 2026 11:13 PM ETIonQ (NYSE:IONQ) Rating Lowered to Sell at Wall Street ZenMarketBeatNYSE:IONQRead IonQ (NYSE:IONQ) Rating Lowered to Sell at Wall Street ZenMay 2, 2026 11:13 PM ETTaskUs (NASDAQ:TASK) Stock Rating Lowered by Wall Street ZenMarketBeatNASDAQ:TASKRead TaskUs (NASDAQ:TASK) Stock Rating Lowered by Wall Street ZenMay 2, 2026 11:13 PM ETWall Street Zen Upgrades Century Therapeutics (NASDAQ:IPSC) to HoldMarketBeatNASDAQ:IPSCRead Wall Street Zen Upgrades Century Therapeutics (NASDAQ:IPSC) to HoldMay 2, 2026 11:13 PM ETUSCB Financial (NASDAQ:USCB) Rating Increased to Hold at Wall Street ZenMarketBeatNASDAQ:USCBRead USCB Financial (NASDAQ:USCB) Rating Increased to Hold at Wall Street ZenMay 2, 2026 11:13 PM ETAnthem (NASDAQ:ANTX) Raised to "Hold" at Wall Street ZenMarketBeatNASDAQ:ANTXRead Anthem (NASDAQ:ANTX) Raised to "Hold" at Wall Street ZenMay 2, 2026 11:13 PM ETU.S. GoldMining (NASDAQ:USGO) Downgraded by Wall Street Zen to SellMarketBeatNASDAQ:USGORead U.S. GoldMining (NASDAQ:USGO) Downgraded by Wall Street Zen to SellMay 2, 2026 11:13 PM ETCAVA Group (NYSE:CAVA) Raised to "Hold" at Wall Street ZenMarketBeatNYSE:CAVARead CAVA Group (NYSE:CAVA) Raised to "Hold" at Wall Street ZenMay 2, 2026 11:13 PM ETTWFG (NASDAQ:TWFG) Lowered to Hold Rating by Wall Street ZenMarketBeatNASDAQ:TWFGRead TWFG (NASDAQ:TWFG) Lowered to Hold Rating by Wall Street ZenMay 2, 2026 11:13 PM ETLineage (NASDAQ:LINE) Downgraded by Wall Street Zen to SellMarketBeatNASDAQ:LINERead Lineage (NASDAQ:LINE) Downgraded by Wall Street Zen to SellMay 2, 2026 11:13 PM ETInfinity Natural Resources (NYSE:INR) Raised to "Strong-Buy" at Wall Street ZenMarketBeatNYSE:INRRead Infinity Natural Resources (NYSE:INR) Raised to "Strong-Buy" at Wall Street ZenMay 2, 2026 11:13 PM ETSolstice Advanced Mat (NASDAQ:SOLS) Upgraded to "Hold" at Wall Street ZenMarketBeatNASDAQ:SOLSRead Solstice Advanced Mat (NASDAQ:SOLS) Upgraded to "Hold" at Wall Street ZenMay 2, 2026 11:13 PM ETGrupo Aeromexico (NYSE:AERO) Lowered to Hold Rating by Wall Street ZenMarketBeatNYSE:AERORead Grupo Aeromexico (NYSE:AERO) Lowered to Hold Rating by Wall Street ZenMay 2, 2026 11:13 PM ETHMH (NASDAQ:HMH) Cut to "Hold" at Wall Street ZenMarketBeatNASDAQ:HMHRead HMH (NASDAQ:HMH) Cut to "Hold" at Wall Street ZenMay 2, 2026 11:12 PM ETZacks Research Brokers Boost Earnings Estimates for MRSHMarketBeatNYSE:MRSHRead Zacks Research Brokers Boost Earnings Estimates for MRSHMay 2, 2026 11:06 PM ETRibbon Communications (NASDAQ:RBBN) Cut to Hold at Wall Street ZenMarketBeatNASDAQ:RBBNRead Ribbon Communications (NASDAQ:RBBN) Cut to Hold at Wall Street ZenMay 2, 2026 11:06 PM ETUltragenyx Pharmaceutical (NASDAQ:RARE) Upgraded to Hold at Wall Street ZenMarketBeatNASDAQ:RARERead Ultragenyx Pharmaceutical (NASDAQ:RARE) Upgraded to Hold at Wall Street ZenMay 2, 2026 11:06 PM ETWall Street Zen Upgrades TXNM Energy (NYSE:TXNM) to "Hold"MarketBeatNYSE:TXNMRead Wall Street Zen Upgrades TXNM Energy (NYSE:TXNM) to "Hold"May 2, 2026 11:06 PM ETPliant Therapeutics (NASDAQ:PLRX) Upgraded at Wall Street ZenMarketBeatNASDAQ:PLRXRead Pliant Therapeutics (NASDAQ:PLRX) Upgraded at Wall Street Zen Featured Articles and OffersThe Real SpaceX Play: 5 Chip Stocks Powering the IPO Before It LaunchesBy Bridget Bennett | May 4, 2026The REAL Reason Trump is Invading IranFrom Banyan Hill Publishing (Ad)Apple Talks Just Changed Everything for IntelBy Sam Quirke | May 6, 20263 Energy Stocks to Buy and 2 to Avoid as AI Power Demand ExplodesBy Bridget Bennett | May 4, 2026Intel (NASDAQ:INTC) Shares Down 3.9% Following Insider SellingBy MarketBeat | May 4, 2026Why this tiny stock may move before the SpaceX IPO dropsFrom Behind the Markets (Ad)5 Stocks to Buy in May Before the Next AI Surge HitsBy Thomas Hughes | May 1, 2026Roblox Stock Slides to New Low as Safety Changes Weigh on OutlookBy Jennifer Ryan Woods | May 3, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 544 of 546 « Most Recent‹ More Recent540541542543544545546 Earlier › Earliest » Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
